• About
    Mission and HistoryExpertsIndependence and TransparencyInternships/Research Fellows
  • Explore Our WorkExplore Our Work
    • Our Work
      • Work
        • Amicus Briefs
        • Diversity and Inclusion
        • Economic & Policy Analysis
        • Fair Fight Film
        • Grant Research
        • Legal Analysis
        • Podcasts
        • Public Comments and Testimony
        • Reports
      • Issues By Sector
        • Airlines
        • Banking & Finance
        • Digital Technology
        • Energy
        • Food & Agriculture
        • Health & Pharmaceuticals
        • Innovation & Entrepreneurship
        • Intellectual Property
        • International
        • Labor
        • Media & Communications
        • Retail & Distribution
        • Transportation
      • Issues By Enforcement Area
        • Buyer Power
        • Cartels
        • Collusion
        • Exemptions & Immunities
        • Mergers
        • Monopolies
        • Private Enforcement
        • Public Enforcement
  • Events
  • Awards
    Alfred E. Kahn Award for Antitrust AchievementAntitrust Enforcement AwardsPrivate Antitrust Enforcement Hall of FameHollis Salzman Memorial Leadership AwardJerry S. Cohen Award for Antitrust Scholarship (administered by Cohen Milstein and hosted by AAI)
  • CLE Programs
  • Support
    Supporting AAIDonateSponsorshipsCy PresGrants
In The News

Stutz Discusses Occupational Licensing and the State-Action Doctrine

October 4, 2016 | Randy Stutz
Exemptions & Immunities , Health & Pharmaceuticals

AAI Associate General Counsel Randy Stutz discussed occupational licensing in the healthcare industry and the state-action doctrine with Weld: Birmingham on October 4, 2016.

Related Work

Podcasts

Countervailing Power: Why It Cannot Save Local Newspapers or Competition

September 27, 2022
Legislation , Exemptions & Immunities , Competition Policy
Economic & Policy Analysis

CPI Antitrust Chronicle Features AAI Analysis on “Market Power Bottlenecks” in Supply Chains

July 5, 2022
Buyer Power , Mergers , Health & Pharmaceuticals , Food & Agriculture
Amicus Briefs

AAI Asks Second Circuit for Clear Thinking When Pharmaceutical Markets Are Monopolized by Patent Fraud (Regeneron v. Novartis)

June 20, 2022 | Randy Stutz
Exclusionary Conduct , Intellectual Property , Monopolies , Health & Pharmaceuticals
In The News

FTC Commissioners Cite AAI Study on Private Equity in Healthcare in Support of Merger Action

June 16, 2022
Competition Policy , FTC , Health & Pharmaceuticals , Mergers , Private Equity , Section 7 of the Clayton Act

Support AAI

Promoting competition that protects consumers, businesses, and society is more important than ever. Through our research, education, and advocacy programs, AAI has been active in focusing public and private competition enforcement priorities and shaping progressive competition policy. The only way for AAI to fulfill its mission is through your support.

Learn More

Address

1025 Connecticut Avenue, NW
Suite 1000
Washington, DC 20036
(202) 828-1226

Join Our Mailing List

    • About
    • Terms of Use
    • Contact Us
    • Support

    Copyright © American Antitrust Institute 2023